Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clotilde Bravetti

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Microbiology Spectrum|March 20, 2025
Development of a new high-yield integration site assay reveals disease-specific patterns across HTLV-1-associated pathologiesVincent Guiraud, Jérôme Alexandre Denis, Sofia Ben Attia, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
The Journal of Molecular Diagnostics : JMD|July 19, 2023
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART AlgorithmMichiel van den Brand, Markus Möbs, Franziska Otto, et al.
Hemasphere|June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline TherapyKamel Laribi, Alix Baugier de Materre, David Ghez, et al.
Hemasphere|August 27, 2025
Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network studyCécile Pivert, Adélaïde Toutée, Christophe Parizot, et al.
Blood|December 6, 2021
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC networkMarion Alcantara, Caroline Houillier, Marie Blonski, et al.
Blood|November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohortPierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
American Journal of Hematology|April 8, 2024
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC networkSylvain Choquet, Carole Soussain, Nabih Azar, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Science (New York, N.Y.)|February 29, 2024
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variantsMarie Materna, Ottavia M Delmonte, Marita Bosticardo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Microbiology Spectrum|March 20, 2025
Development of a new high-yield integration site assay reveals disease-specific patterns across HTLV-1-associated pathologiesVincent Guiraud, Jérôme Alexandre Denis, Sofia Ben Attia, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
The Journal of Molecular Diagnostics : JMD|July 19, 2023
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART AlgorithmMichiel van den Brand, Markus Möbs, Franziska Otto, et al.
Hemasphere|June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline TherapyKamel Laribi, Alix Baugier de Materre, David Ghez, et al.
Hemasphere|August 27, 2025
Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network studyCécile Pivert, Adélaïde Toutée, Christophe Parizot, et al.
Blood|December 6, 2021
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC networkMarion Alcantara, Caroline Houillier, Marie Blonski, et al.
Blood|November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohortPierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
American Journal of Hematology|April 8, 2024
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC networkSylvain Choquet, Carole Soussain, Nabih Azar, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Science (New York, N.Y.)|February 29, 2024
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variantsMarie Materna, Ottavia M Delmonte, Marita Bosticardo, et al.
Pageof 3